We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

125 hedge funds and large institutions have $880M invested in Aurinia Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

54% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 26

23% more call options, than puts

Call options by funds: $34.3M | Put options by funds: $28M

9% more funds holding

Funds holding: 115 → 125 (+10)

8.33% more ownership

Funds ownership: 45.7% → 54.03% (+8.3%)

11% less capital invested

Capital invested by funds: $992M → $880M (-$111M)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
125
Holders Change
+10
Holders Change %
+8.7%
% of All Funds
2.75%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
33
Increased
40
Reduced
26
Closed
20
Calls
$34.3M
Puts
$28M
Net Calls
+$6.38M
Net Calls Change
-$43.4M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$87.2M
2
ACA
Avoro Capital Advisors
New York
+$30.4M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
+$28.5M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$19M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$18.9M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$27.1M
2
O
OrbiMed
New York
-$17.8M
3
PA
Perceptive Advisors
New York
-$14.5M
4
CLCM
Crawford Lake Capital Management
New Jersey
-$7.25M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$1.13M -$471K -26,689 -26%
Two Sigma Advisers
52
Two Sigma Advisers
New York
$1.07M +$1.3M +73,800 New
UBS AM
53
UBS AM
Illinois
$1.05M +$321K +18,200 +33%
CS
54
Credit Suisse
Switzerland
$1.02M +$366K +20,734 +42%
Creative Planning
55
Creative Planning
Kansas
$994K -$3.48M -197,200 -74%
EAM
56
Erste Asset Management
Austria
$970K – – –
NFG
57
Norris Financial Group
South Carolina
$947K +$190K +10,758 +20%
LP
58
LMR Partners
United Kingdom
$935K +$1.12M +63,633 New
Stifel Financial
59
Stifel Financial
Missouri
$894K +$216K +12,258 +25%
Verition Fund Management
60
Verition Fund Management
Connecticut
$871K +$247K +13,999 +30%
FAM
61
Fred Alger Management
New York
$813K +$159K +9,000 +19%
Morgan Stanley
62
Morgan Stanley
New York
$809K -$3.34M -189,497 -77%
GIA
63
Gladstone Institutional Advisory
Florida
$797K +$968K +54,902 New
SM
64
Sabby Management
Florida
$617K +$750K +42,500 New
RJA
65
Raymond James & Associates
Florida
$602K +$230K +13,050 +46%
HT
66
HAP Trading
New York
$543K +$380K +21,570 +136%
ERSOT
67
Employees Retirement System of Texas
Texas
$525K – – –
BFM
68
Boothbay Fund Management
New York
$515K -$889K -50,428 -59%
Squarepoint
69
Squarepoint
New York
$509K +$106K +5,989 +21%
CSS
70
Cubist Systematic Strategies
Connecticut
$499K +$548K +31,080 +940%
CM
71
Caption Management
Oklahoma
$497K +$162K +9,200 +37%
Two Sigma Investments
72
Two Sigma Investments
New York
$357K +$434K +24,599 New
SEC
73
Seven Eight Capital
New York
$353K +$429K +24,300 New
Bank of America
74
Bank of America
North Carolina
$306K +$208K +11,779 +127%
CL
75
CSS LLC
Illinois
$263K +$316K +17,903 +8,064%
1 2
3
4 5

AUPH Hedge Fund Activity: Q1 2020 in Review

125 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q1 2020, worth a combined $880M — down 11% from $992M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new AUPH positions and 20 closed out — a net gain of 13 holders — while 40 added to existing stakes and 26 trimmed.

The largest buyer was HealthCor Management, adding an estimated $87.2M. The largest seller was Millennium Management, cutting an estimated $27.1M.

  • 125 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q1 2020, up from 115 in Q4 2019.
  • Funds reported $880M of Aurinia Pharmaceuticals stock for Q1 2020, down 11% quarter-over-quarter.
  • 33 funds opened new Aurinia Pharmaceuticals positions in Q1 2020 and 20 closed out, a net change of +13 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q1 2020 was HealthCor Management, an estimated $87.2M added.
  • The largest Aurinia Pharmaceuticals seller in Q1 2020 was Millennium Management, an estimated $27.1M sold.

Based on aggregated 13F filings for Q1 2020.